Blog
Novavax (NVAX) Profit Jumps on Milestone
Novavax (NASDAQ:NVAX), known for its protein-based vaccine technology, released its second quarter fiscal 2025 results on August 6, 2025. The standout news was a return to profitability on a GAAP
Parsons (PSN) Q2 EPS Beats by 5%
Parsons (NYSE:PSN), a global provider of technology-driven solutions for critical infrastructure, defense, and cybersecurity, released its Q2 FY2025 earnings on August 6, 2025. The company delivered
Why Scholar Rock Stock Wilted on Wednesday
It didn't take a high-powered academic to figure out why Scholar Rock's (NASDAQ: SRRK) share price swooned by more than 5% on Wednesday. That morning, the biotech published a quarterly earnings
Avista (AVA) Q2 EPS Drops 41%
Avista (NYSE:AVA), a regional regulated electric and natural gas utility serving the Pacific Northwest and Alaska, reported earnings on August 5, 2025, for the second quarter of fiscal 2025. The
COPT Defense Properties (CDP) Q2 2025 Earnings Transcript
Image source: The Motley Fool.
Tuesday, July 29, 2025, at 12 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
OptimumBank (OPHC) Q2 EPS Jumps 93%
OptimumBank (NYSEMKT:OPHC), a community bank focused on the South Florida market, reported its Q2 2025 earnings on August 6, 2025. The most notable news in this release was a significant
Amentum (AMTM) Q3 Revenue Jumps 66%
Amentum (NYSE:AMTM), a leading provider of engineering, technical, and mission support services to government and commercial customers, reported results for Q3 FY2025 on August 5, 2025. The earnings
Scholar Rock (SRRK) Q2 Loss Widens 63%
Scholar Rock (NASDAQ:SRRK), a late-stage biopharmaceutical company specializing in therapies for serious neuromuscular and rare diseases, released its second quarter 2025 earnings on August 6, 2025
Bentley (BSY) Q2 Revenue Up 10%
Bentley Systems (NASDAQ:BSY), a global provider of infrastructure engineering software, reported its second quarter 2025 financial results on August 6, 2025. The most notable outcome was a beat on
Howard Hughes (HHH) Q2 EPS Falls 123%
Howard Hughes (NYSE:HHH), a leading developer of master planned communities and mixed-use real estate, reported earnings for Q2 FY2025 on August 6, 2025. The headline news from the release was a
Lexicon (LXRX) Q2 Revenue Soars 1,706%
Lexicon Pharmaceuticals (NASDAQ:LXRX), a biopharma company focused on developing treatments for diabetes, cardiovascular, and neurological diseases, released its second quarter 2025 financial
AtriCure (ATRC) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, July 29, 2025, at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
RYAM Sales Drop 19%
Rayonier Advanced Materials (NYSE:RYAM), a leading manufacturer of high-purity cellulose and related plant-based products, reported Q2 FY2025 earnings on August 5, 2025. The earnings release
Adient (ADNT) Q3 Revenue Up 0.7%
Adient (NYSE:ADNT), a leading global manufacturer specializing in automotive seating systems for major vehicle producers, released its fiscal third-quarter earnings on August 6, 2025. The most
American Coastal (ACIC) Q2 EPS Jumps 36%
American Coastal Insurance (NASDAQ:ACIC), a specialist in Florida commercial residential insurance, reported its second quarter 2025 financial results on August 6, 2025. The company posted diluted
APEI Earnings Rise 6%
American Public Education (NASDAQ:APEI), an online and campus-based provider specializing in military, nursing, and public service education, released its second quarter results on August 6, 2025
Centuri (CTRI) Q2 Revenue Jumps 8%
Centuri (NYSE:CTRI), a major North American utility infrastructure services provider, reported its fiscal second quarter 2025 results on August 6, 2025. The headline news was strong revenue, which
Ameris (ABCB) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, July 29, 2025, at 9 a.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
EyePoint (EYPT) Q2 Revenue Drops 44%
EyePoint Pharmaceuticals (NASDAQ:EYPT), a biopharmaceutical company specializing in sustained-release treatments for retinal diseases, reported its second quarter 2025 results on August 6, 2025. The
Dave (DAVE) Q2 EPS Jumps 211%
Dave (NASDAQ:DAVE), a digital finance platform focused on providing banking and credit solutions to financially vulnerable Americans, released its second quarter fiscal 2025 earnings on August 6
NRP Net Income Drops 26%
Natural Resource Partners (NYSE:NRP), a diversified owner of mineral rights and interests primarily in coal and soda ash, released its Q2 2025 results on Aug. 6, 2025. In this earnings update, the
Ardent Health (ARDT) Q2 EPS Jumps 126%
Ardent Health (NYSE:ARDT), a major hospital and healthcare system operating in fast-growing mid-sized urban markets, reported second quarter 2025 results on August 5, 2025. The earnings release
Is It Time to Buy Biotech Stocks?
In this podcast, Motley Fool analysts Tim Beyers and Karl Thiel discuss:
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest
Charles River (CRL) Q2 EPS Jumps 11%
Charles River Laboratories International (NYSE:CRL), a global provider of laboratory services and research models for drug development, announced its latest earnings results on August 6, 2025. The
Riot (RIOT) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, July 31, 2025, at 4:30 p.m. ET
For analyst commentary or quotes, please email [email protected]
Source Fool.com